NCT01759836View on ClinicalTrials.gov

Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Prostatic Neoplasms
Interventions
DRUG

Atorvastatin 20mg

Atorvastatin 20mg daily for 1 year

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

Dong-A Pharmaceutical
All Listed Sponsors
collaborator

Dong-A Pharmaceutical

INDUSTRY

lead

Asan Medical Center

OTHER

NCT01759836 - Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter